Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $43.55 | 3 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $29.90 | 2 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $13.65 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $43.55 | 3 | Novo Nordisk Inc ($29.90) |
All Payment Transactions
3 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/21/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/18/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Diabetes | ||||||
| 05/12/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 8 | 417 | 724 | $142,932 | $30,854 |
| 2021 | 9 | 613 | 1,050 | $223,728 | $51,175 |
| 2020 | 8 | 726 | 1,334 | $240,125 | $60,944 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 111 | 198 | $95,238 | $18,824 | 19.8% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2022 | 65 | 202 | $17,574 | $4,137 | 23.5% |
| 95250 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | Office | 2022 | 26 | 30 | $11,970 | $3,647 | 30.5% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 107 | 158 | $4,740 | $1,517 | 32.0% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 46 | 57 | $5,301 | $1,269 | 23.9% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 14 | 19 | $6,479 | $980.20 | 15.1% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 19 | 22 | $1,364 | $356.32 | 26.1% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 29 | 38 | $266.00 | $124.08 | 46.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 184 | 371 | $172,144 | $37,828 | 22.0% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2021 | 76 | 139 | $11,676 | $2,996 | 25.7% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 174 | 308 | $9,240 | $2,964 | 32.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 32 | 41 | $13,653 | $2,718 | 19.9% |
| 95250 | Ambulatory continuous glucose (sugar) monitoring for a minimum of 72 hours | Office | 2021 | 17 | 18 | $7,488 | $2,067 | 27.6% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 41 | 59 | $5,310 | $1,298 | 24.5% |
| 95249 | Continuous monitoring of glucose in tissue fluid using sensor under skin | Office | 2021 | 18 | 18 | $2,790 | $767.84 | 27.5% |
| 92250 | Photography of the retina | Office | 2021 | 13 | 15 | $859.50 | $275.70 | 32.1% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2021 | 58 | 81 | $567.00 | $259.12 | 45.7% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 232 | 525 | $187,950 | $45,611 | 24.3% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 68 | 88 | $23,241 | $6,379 | 27.4% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 219 | 440 | $13,200 | $4,185 | 31.7% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2020 | 42 | 78 | $6,942 | $1,870 | 26.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 19 | 21 | $5,586 | $1,052 | 18.8% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 41 | 42 | $1,260 | $819.57 | 65.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 41 | 42 | $1,260 | $713.82 | 56.7% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2020 | 64 | 98 | $686.00 | $312.92 | 45.6% |
About Joan Manzella, ARNP
Joan Manzella, ARNP is a Registered Nurse healthcare provider based in Colville, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/15/2015. The National Provider Identifier (NPI) number assigned to this provider is 1861857039.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Joan Manzella, ARNP has received a total of $43.55 in payments from pharmaceutical and medical device companies, with $43.55 received in 2022. These payments were reported across 3 transactions from 2 companies. The most common payment nature is "Food and Beverage" ($43.55).
As a Medicare-enrolled provider, Manzella has provided services to 1,756 Medicare beneficiaries, totaling 3,108 services with total Medicare billing of $142,972. Data is available for 3 years (2020–2022), covering 25 distinct procedure/service records.
Practice Information
- Specialty Registered Nurse
- Other Specialties Nurse Practitioner, Family
- Location Colville, WA
- Active Since 12/15/2015
- Last Updated 04/30/2025
- Taxonomy Code 163W00000X
- Entity Type Individual
- NPI Number 1861857039
Products in Payments
- Rybelsus (Drug) $15.13
- Ozempic (Drug) $14.77
- FARXIGA (Drug) $13.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Colville
Diana Rambow
Registered Nurse — Payments: $208.74
Kaylee Oberbarnscheidt
Registered Nurse — Payments: $21.38
Priscilla Ory, R.n, R.N
Registered Nurse
Michael John, Rn, RN
Registered Nurse
Tiffany Ochs
Registered Nurse
David Tobias
Registered Nurse